Relationship among CFH and ARMS2 genotypes, macular pigment optical density, and neuroretinal function in persons without age-related macular degeneration

Archives of Ophthalmology

Volumn 130, Issue 11, 2012, Pages 1402-1409

  Feigl, Beatrix ^a,b   Morris, C Phillip ^a   Brown, Brian ^a   Zele, Andrew J ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b QUEENSLAND EYE INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARMS2 PROTEIN; COMPLEMENT H PROTEIN; EYE PROTEIN; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MACULAR PIGMENT OPTICAL DENSITY; MALE; NEURORETINA; OPHTHALMOSCOPY; OPTICAL DENSITY; PHOTOMETRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION;

EID: 84869123294     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2012.1940     Document Type: Article

References (82)

1. Brown B, Tobin C, Roche N, Wolanowski A. Cone adaptation in age-related maculopathy. Am J Optom Physiol Opt. 1986;63(6):450-454. (Pubitemid 16020471)
2. Collins M, Brown B. Glare recovery and its relation to other clinical findings in age related maculopathy. Clin Vis Sci. 1989;4:155-163. (Pubitemid 19109748)
3. Haegerstrom-Portnoy G, Brown B. Two-color increment thresholds in early age-related maculopathy. Clin Vis Sci. 1989;4:165-172. (Pubitemid 19109749)
4. Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(9):3355-3360. (Pubitemid 39121876)
5. Feigl B, Brown B, Lovie-Kitchin J, Swann PG. Cone-mediated multifocal electroretinogram in early age-related maculopathy and its relationships with subjective macular function tests. Curr Eye Res. 2004;29(4-5):327-336. (Pubitemid 40095018)
6. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Cone- and rod-mediated multifocal electroretinogram in early age-related maculopathy. Eye (Lond). 2005;19(4):431-441. (Pubitemid 40553145)
7. Feigl B, Brown B, Lovie-Kitchin J, Swann PG. Adaptation responses in early age-related maculopathy. Invest Ophthalmol Vis Sci. 2005;46(12):4722-4727. (Pubitemid 44264576)
8. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Mid-frequency loss of foveal flicker sensitivity in early stages of age-related maculopathy. Invest Ophthalmol Vis Sci. 1992;33(11):3136-3142.
9. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108(7):1196-1202. (Pubitemid 32568127)
10. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev. 2002;1(3):381-396. (Pubitemid 38340331)
11. Zele AJ, O'Loughlin RK, Guymer RH, Vingrys AJ. Disclosing disease mechanisms with a spatio-temporal summation paradigm. Graefes Arch Clin Exp Ophthalmol. 2006;244(4):425-432.
12. Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci. 2008;49(1):55-65.
13. Feigl B, Brown B, Lovie-Kitchin J, Swann PG. The rod-mediated multifocal electroretinogram in aging and in early age-related maculopathy. Curr Eye Res. 2006;31(7-8):635-644. (Pubitemid 44179990)
14. Brown B, Adams AJ, Coletta NJ, Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthalmic Physiol Opt. 1986;6(1):81-84. (Pubitemid 16157540)
15. Collins M, Brown B. Glare recovery and age-related maculopathy. Clin Vis Sci. 1989;4:145-153.
16. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Foveal flicker sensitivity discriminates ARM-risk from healthy eyes. Invest Ophthalmol Vis Sci. 1992;33(11):3143-3149.
17. Falsini B, Fadda A, Iarossi G, et al. Retinal sensitivity to flicker modulation: reduced by early age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41(6):1498-1506. (Pubitemid 30261876)
18. Sutter EE, Tran D. The field topography of ERG components in man: I, the photopic luminance response. Vision Res. 1992;32(3):433-446.
19. Tzekov RT, Gerth C, Werner JS. Senescence of human multifocal electroretinogram components: a localized approach. Graefes Arch Clin Exp Ophthalmol. 2004;242(7):549-560. (Pubitemid 39157682)
20. Gerth C, Delahunt PB, Alam S, Morse LS, Werner JS. Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up. Arch Ophthalmol. 2006;124(3):345-352.
21. Feigl B, Lovie-Kitchin J, Brown B. Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram. Clin Exp Optom. 2005;88(5):304-312.
22. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Postreceptoral adaptation abnormalities in early age-related maculopathy. Vis Neurosci. 2006;23(6):863-870. (Pubitemid 46456692)
23. Gin TJ, Luu CD, Guymer RH. Central retinal function as measured by the multifocal electroretinogram and flicker perimetry in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(12):9267-9274.
24. Wood A, Margrain T, Binns A. The effect of bleach duration and age on the ERG photostress test. Graefes Arch Clin Exp Ophthalmol. 2011;249(9):1359-1365.
25. Gaffney AJ, Binns AM, Margrain TH. Topography of cone dark adaptation deficits in age-related maculopathy. Optom Vis Sci. 2011;88(9):1080-1087.
26. Feigl B. Age-related maculopathy-linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res. 2009;28(1):63-86.
27. Hogg RE, Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res. 2006;25(3):249-276. (Pubitemid 43782815)
28. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37(7):1236-1249. (Pubitemid 26177300)
29. Bird AC, Barnes RM. Age-related macular disease: an ongoing challenge. Clin Experiment Ophthalmol. 2003;31(6):461-463. (Pubitemid 38049220)
30. Feigl B, Morris CP. The challenge of predicting macular degeneration. Curr Med Res Opin. 2011;27(9):1745-1748.
31. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007;297(16):1793-1800. (Pubitemid 46658648)
32. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50(5):2044-2053.
33. Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology. 2011;118(11):2203- 2211.
34. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006;38(9):1055-1059. (Pubitemid 44325932)
35. Williamson JF, McLure CA, Guymer RH, et al. Almost total protection from age-related macular degeneration by haplotypes of the Regulators of Complement Activation. Genomics. 2011;98(6):412-421.
36. Feigl B, Cao D, Morris CP, Zele AJ. Persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision. Invest Ophthalmol Vis Sci. 2011;52(2):1145-1150.
37. Loane E, Nolan JM, McKay GJ, Beatty S. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype. Exp Eye Res. 2011;93(5):592-598.
38. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385-389. (Pubitemid 40530070)
39. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006;314(5801):992-993. (Pubitemid 44749944)
40. Palmowski AM, Berninger T, Allgayer R, Andrielis H, Heinemann-Vernaleken B, Rudolph G. Effects of refractive blur on the multifocal electroretinogram. Doc Ophthalmol. 1999;99(1):41-54. (Pubitemid 30495269)
41. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001;132(5):668-681.
42. Bearse MAJ Jr, Han Y, Schneck ME, Adams AJ. Retinal function in normal and diabetic eyes mapped with the slow flash multifocal electroretinogram. Invest Ophthalmol Vis Sci. 2004;45(1):296-304. (Pubitemid 38055701)
43. Sutter EE, Shimada Y, Li Y, Bearse MAJ. Mapping inner retinal function through enhancement of adaptative components in the M-ERG. In: Vision Science and Its Application. Washington, DC: Optical Society of America; 1999:52-55.
44. Hood DC, Frishman LJ, Saszik S, Viswanathan S. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci. 2002;43(5):1673-1685. (Pubitemid 34462674)
45. Rangaswamy NV, Hood DC, Frishman LJ. Regional variations in local contributions to the primate photopic flash ERG: revealed using the slow-sequence mfERG. Invest Ophthalmol Vis Sci. 2003;44(7):3233-3247. (Pubitemid 36759797)
46. Hood DC, Bach M, Brigell M, et al International Society For Clinical Electrophysiology of Vision. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2011;124(1):1-13.
47. Swann PG, Lovie-Kitchin JE. Age-related maculopathy: II, the nature of the central visual field loss. Ophthalmic Physiol Opt. 1991;11(1):59-70.
48. Wooten BR, Hammond BR Jr, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci. 1999;40(11):2481-2489. (Pubitemid 29455474)
49. Raman R, Rajan R, Biswas S, Vaitheeswaran K, Sharma T. Macular pigment optical density in a South Indian population. Invest Ophthalmol Vis Sci. 2011;52(11):7910-7916.
50. Foerster MH, Kellner U, Wessing A. Cone dystrophy and supernormal dark-adapted b-waves in the electroretinogram. Graefes Arch Clin Exp Ophthalmol. 1990;228(2):116-119. (Pubitemid 20095814)
51. Gouras P, MacKay CJ. Supernormal cone electroretinograms in central retinal vein occlusion. Invest Ophthalmol Vis Sci. 1992;33(3):508-515.
52. Feigl B, Haas A, El-Shabrawi Y. Multifocal ERG in multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol. 2002;240(8):615-621. (Pubitemid 36075621)
53. Stanford MR, Robbins J. Experimental posterior uveitis: II, electroretinographic studies. Br J Ophthalmol. 1988;72(2):88-96. (Pubitemid 18063703)
54. Ikeda H, Franchi A, Turner G, Shilling J, Graham E. Electroretinography and electrooculography to localize abnormalities in early-stage inflammatory eye disease. Doc Ophthalmol. 1989;73(4):387-394. (Pubitemid 20166934)
55. Knave B. The ERG and ophthalmological changes in experimental metallosis in the rabbit: 1, effes of iron particles. Acta Ophthalmol (Copenh). 1970;48(1):136-158.
56. Gouras P, Eggers HM, MacKay CJ. Conedystrophy, nyctalopia, and supernormal rod responses: a new retinal degeneration. Arch Ophthalmol. 1983;101(5):718-724. (Pubitemid 13133101)
57. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108(4):697-704. (Pubitemid 32238465)
58. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428-435.
59. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51(2):137-152. (Pubitemid 43269939)
60. Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29(2):95-112.
61. Jain N, Farsiu S, Khanifar AA, et al. Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci. 2010;51(10):4875-4883.
62. Zele AJ, Cao D, Pokorny J. Rod-cone interactions and the temporal impulse response of the cone pathway. Vision Res. 2008;48(26):2593-2598.
63. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000;19(5):607-646. (Pubitemid 30488087)
64. Kremers J, Czop D, Link B. Rod and S-cone driven ERG signals at high retinal illuminances. Doc Ophthalmol. 2009;118(3):205-216.
65. Mohand-Said S, Deudon-Combe A, Hicks D, et al. Normal retina releases a diffusible factor stimulating cone survival in the retinal degeneration mouse. Proc Natl Acad Sci U S A. 1998;95(14):8357-8362. (Pubitemid 28326117)
66. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34(12):3278-3296. (Pubitemid 23346660)
67. Curcio CA. Photoreceptor topography in ageing and age-related maculopathy. Eye (Lond). 2001;15(pt 3):376-383. (Pubitemid 32605667)
68. Hoang QV, Linsenmeier RA, Chung CK, Curcio CA. Photoreceptor inner segments in monkey and human retina: mitochondrial density, optics, and regional variation. Vis Neurosci. 2002;19(4):395-407. (Pubitemid 36019862)
69. Curcio CA, Owsley C, Jackson GR. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41(8):2015-2018. (Pubitemid 30450964)
70. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134(3):411-431.
71. Hageman GS, Mullins RF. Molecular composition of drusen as related to substructural phenotype. Mol Vis. 1999;5:28.
72. Charng J, Nguyen CT, Bui BV, Vingrys AJ. Age-related retinal function changes in albino and pigmented rats. Invest Ophthalmol Vis Sci. 2011;52(12):8891-8899.
73. Gao H, Hollyfield JG. Aging of the human retina: differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1992;33(1):1-17.
74. Gerth C, Hauser D, Delahunt PB, Morse LS, Werner JS. Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol. 2003;121(10):1404-1414. (Pubitemid 37243741)
75. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol. 2007;125(1):55-62. (Pubitemid 46072376)
76. Jelcick AS, Yuan Y, Leehy BD, et al. Genetic variations strongly influence phenotypic outcome in the mouse retina. PLoS One. 2011;6(7):e21858.
77. Gundogan FC, Sobaci G, Bayraktar MZ. Intra-sessional and inter-sessional variability of multifocal electroretinogram. Doc Ophthalmol. 2008;117(3):175-183.
78. Harrison WW, Bearse MA Jr, Ng JS, et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci. 2011;52(2):772-777.
79. Feigl B, Stewart IB, Brown B, Zele AJ. Local neuroretinal function during acute hypoxia in healthy older people. Invest Ophthalmol Vis Sci. 2008;49(2):807-813.
80. Grunwald JE, Metelitsina TI, Dupont JC, Ying GS, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci. 2005;46(3):1033-1038. (Pubitemid 41321042)
81. Moschos MM, Brouzas D, Chatziralli IP, Ladas I. Ranibizumab in the treatment of choroidal neovascularisation due to age-relatedmacular degeneration: an optical coherence tomography and multifocal electroretinography study. Clin Exp Optom. 2011;94(3):268-275.
82. Moschos MM, Panayotidis D, Theodossiadis GP, Moschos M. Assessment of macular function by multifocal electroretinogram in age-related macular degeneration before and after photodynamic therapy. J Fr Ophtalmol. 2004;27(9, pt 1):1001-1006. (Pubitemid 39556827)